Funded Tech Companies
Mediar Therapeutics
Mediar Therapeutics, operating out of North Cambridge, received equity investments from Eli Lilly and Company, Pfizer Venture Investments and Ono Venture Investment.
Company Overview
Company Name
Mediar Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
700 Main St.
North Cambridge, MA 02139
USA
North Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Mediar is a discovery stage biotechnology company developing treatments to halt, or even reverse, fibrosis. Our platform and pipeline are based on an emerging class of novel targets -- fibrotic mediators -- that play key roles in modulating myofibroblasts.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/15/2023
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Meredith Fisher
Chief Scientific Officer
Paul Yaworsky
Company Investors
- Eli Lilly and Company
- Pfizer Venture Investments (Nikola Trbovic)
- Ono Venture Investment (Hiroshi Yamamoto)
- Novartis Venture Fund
- Mass General Brigham Ventures
- Sofinnova Partners
- Mission BioCapital
- Pureos Bioventures
- Bristol Myers Squibb
- GIMV
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs